Scott Ethan M, Smith Brandon, Liu Joseph, Hoffman Karlee, Hershberger Jennifer, Crosby Andew, Baple Emma L, Wenger Olivia K
New Leaf Center Clinic for Special Children, 16014 East Chestnut Street Mount Eaton, OH, USA.
Department of Pediatrics, Akron Children's Hospital, 214 W Bowery St, Akron, OH 44308, USA.
Mol Genet Metab Rep. 2024 Nov 20;41:101161. doi: 10.1016/j.ymgmr.2024.101161. eCollection 2024 Dec.
Propionic acidemia (PA) is an inborn error of metabolism (IEM) that typically presents in the newborn. The Amish of North America have an increased prevalence of PA due to a founder variant in the gene. The Amish PA phenotype is variable, and some individuals remain asymptomatic and undiagnosed until adulthood. Additionally, there are limited reports of pregnancy outcomes in Amish individuals with PA.
A retrospective single center chart review was completed on sixty Amish individuals with PA to identify individuals diagnosed as adults (18 years or older) and pregnancy outcomes. We assessed age at diagnosis, reason for PA testing, medical history prior to diagnosis including developmental delay, seizure, protein intolerance, cardiac symptoms, and anxiety. Following the diagnosis, we assessed the prevalence of prolonged QTc and dilated cardiomyopathy. We assessed our cohort for number of pregnancies, pregnancy outcomes, and peripartum complications.
Nine out of sixty individuals (15 %) were diagnosed with PA as adults. A family member with PA was the most common reason to prompt genetic testing. Cardiac symptoms were present in six of nine individuals prior to diagnosis. Three individuals diagnosed as adults had dilated cardiomyopathy and one underwent cardiac transplant. There were twenty-one pregnancies in six women with eighteen successful deliveries and three miscarriages. Two women developed peripartum cardiomyopathy. There were no acute maternal decompensations.
Our work supports the consideration that all Amish newborns be screened for PA with molecular testing to enable early diagnosis. The stark difference in peripartum outcomes requires further prospective work to ensure appropriate monitoring throughout pregnancy while respecting individual values and autonomy.
丙酸血症(PA)是一种先天性代谢缺陷病(IEM),通常在新生儿期出现。由于一个奠基者变异基因,北美阿米什人群中PA的患病率有所增加。阿米什PA患者的表型存在差异,一些个体直到成年仍无症状且未被诊断。此外,关于阿米什PA患者妊娠结局的报道有限。
对60例阿米什PA患者进行回顾性单中心病历审查,以确定成年(18岁及以上)诊断的个体及妊娠结局。我们评估了诊断年龄、PA检测原因、诊断前的病史,包括发育迟缓、癫痫、蛋白质不耐受、心脏症状和焦虑。诊断后,我们评估了QTc延长和扩张型心肌病的患病率。我们评估了队列中的妊娠次数、妊娠结局和围产期并发症。
60例个体中有9例(15%)成年后被诊断为PA。有PA家族成员是促使进行基因检测的最常见原因。9例个体中有6例在诊断前出现心脏症状。3例成年诊断患者患有扩张型心肌病,1例接受了心脏移植。6名女性共有21次妊娠,18次成功分娩,3次流产。2名女性发生围产期心肌病。没有急性母体失代偿情况。
我们的研究支持对所有阿米什新生儿进行PA分子检测筛查以实现早期诊断的考虑。围产期结局的显著差异需要进一步的前瞻性研究,以确保在尊重个体价值观和自主权的同时,在整个孕期进行适当监测。